- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05596448
Coccygeal Nerve Radiofrequency Treatment in Coccydynia
October 26, 2022 updated by: Damla Yürük, Diskapi Teaching and Research Hospital
Investigation of the Efficiency of Coccygeal Nerve Radiofrequency Treatment in Coccydynia'
Coccydynia or coccygeal pain is a painful syndrome that affects the coccyx region.
The most important etiological factors in the formation of coccidynia are; external and internal trauma.
Patients with coccydynia typically complain of coccyx pain.
This pain increases with prolonged sitting, bending backwards during sitting, standing for long periods of time, and standing up after sitting.
Conservative treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs), levator sudden relaxation exercises, seat cushions, and transcutaneous electrical simulation have all been used to relieve pain, but these methods are ineffective in 10% of patients.
In the patient group unresponsive to conservative treatments, there are various interventional treatment options, including caudal epidural steroid injection, ganglion impar blocks, radiofrequency ablation of the sacral nerves, block of the coccygeal nerves and radiofrequency ablation, and coccygectomy.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
In algoloji clinic, routinely apply ultrasound-guided coccygeal nerve block and radiofrequency ablation to patients with coccydynia.
During the procedure, after imaging the sacral and coccygeal corns with ultrasonography, a radiofrequency ablation needle is inserted at the level of the coccygeal horn and radiofrequency ablation is applied at 90 degrees for 60 seconds.
Patients are followed for a while in our post-procedure service for possible hypotension and allergic reactions.
In this study, it was planned to apply the Visual Pain Scale (VAS) and Paris Functional Coccydynia Questionnaire at the 1st week, 1st month and 3rd months after the treatment to patients who had coccygeal nerve block and radiofrequency ablation in our clinic due to the complaint of coccydynia resistant to conservative treatment methods.
In this way, it is planned to evaluate the efficacy of treatment.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Diskapi Yildirim Beyazıt Teaching and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 63 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Coccygeal pain
Exclusion Criteria:
- Malignancy
- İnfection
- Coagulation disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cocygeal nerve radiofrequency ablation group
During the procedure, after imaging the sacral and coccygeal corns with ultrasonography, a radiofrequency ablation needle is inserted at the level of the coccygeal horn and radiofrequency ablation is applied at 90 degrees for 60 seconds.
|
During the procedure, after imaging the sacral and coccygeal corns with ultrasonography, a radiofrequency ablation needle is inserted at the level of the coccygeal horn and radiofrequency ablation is applied at 90 degrees for 60 seconds.
|
No Intervention: Conservative treatment group
This group includes patients receiving conservative treatment such as nonsteroidal anti-inflammatory group drugs, physical therapy, and exercise for coccygeal pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Paris Functional Coccydynia Questionnaire
Time Frame: 4 weeks
|
It is a scale that measures the severity of coccygeal pain.
Scored between ''0: no pain'' and ''10: worst pain.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual analog scale (VAS)
Time Frame: 4 weeks
|
It is a scale that measures the severity of pain.
In this questionnaire, the patient's pain in sitting position, getting up from sitting position, standing and walking, traveling and at night is recorded.
Scored between ''0: no pain'' and ''10: worst pain.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ömer Taylan Akkaya, Diskapi Yildirim Beyazıt Teaching and Research Hospital
- Study Chair: Gevher Rabia Genç Perdecioğlu, Diskapi Yildirim Beyazıt Teaching and Research Hospital
- Study Chair: Hüseyin Alp Alptekin, Diskapi Yildirim Beyazıt Teaching and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 22, 2022
Primary Completion (Anticipated)
October 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
October 22, 2022
First Submitted That Met QC Criteria
October 26, 2022
First Posted (Actual)
October 27, 2022
Study Record Updates
Last Update Posted (Actual)
October 27, 2022
Last Update Submitted That Met QC Criteria
October 26, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- Coccygeal Nerve
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coccyx Disorder
-
Sisli Hamidiye Etfal Training and Research HospitalRecruitingCoccyx Disorder | Coccyx InjuryTurkey
-
Fatih Sultan Mehmet Training and Research HospitalRecruitingCoccyx Disorder | Coccygodynia | Coccyx InjuryTurkey
-
Riphah International UniversityRecruiting
-
Cumhuriyet UniversityRecruiting
-
KTO Karatay UniversityCompleted
-
Yuzuncu Yıl UniversityCompletedCoccyx DisorderTurkey
-
Nantes University HospitalNot yet recruiting
-
Barts & The London NHS TrustCompleted
-
Yuzuncu Yıl UniversityCompleted
-
Nantes University HospitalRecruitingNeuropathic Pain | Coccyx Disorder | CoccygodyniaFrance
Clinical Trials on Coccygeal nerve radiofrequency ablation
-
University of UtahEnrolling by invitationTotal Knee ArthroplastyUnited States
-
Pamukkale UniversityRecruitingKnee Osteoarthritis | Knee Pain ChronicTurkey
-
Henry Ford Health SystemTerminatedChronic Knee PainUnited States
-
Assiut UniversityRecruitingLumbar Facet Joint PainEgypt
-
Randall Brewer, MD, CPIAbbott Medical Devices; AbbottCompletedOsteoarthritis, Knee | Chronic Knee PainUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedHepatocellular CancerFrance
-
Xijing HospitalUnknown
-
Ain Shams UniversityRecruiting
-
Oxford University Hospitals NHS TrustRoyal Bournemouth and Christchurch Hospitals NHS Foundation TrustCompleted
-
Allevio Pain Management ClinicRecruitingShoulder Pain Chronic | Faceto-genic Neck Pain | Faceto-genic HeadacheCanada